Skip to main content
Celemics, Inc. logo

Celemics, Inc. — Investor Relations & Filings

Ticker · 331920 ISIN · KR7331920009 KO Manufacturing
Open in API
Filings indexed 180 across all filing types
Latest filing 2023-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 331920

About Celemics, Inc.

https://www.celemics.com/

Celemics, Inc. is a biotechnology company that develops and provides Next-Generation Sequencing (NGS) solutions for research and clinical applications. The company specializes in hybridization-based target enrichment technology, offering a comprehensive portfolio of products and services. This includes ready-to-use and customized NGS panels, whole exome sequencing kits, library preparation kits, modular accessories, and bioinformatics analysis services. Celemics' solutions support a wide range of fields, including oncology (somatic cancer, liquid biopsy), inherited diseases, pathogen analysis, pharmacogenomics, and immune repertoire profiling. A key focus is the development of end-to-end customized target enrichment panels, providing support from assay design and optimization to complete bioinformatics analysis. The company's proprietary technologies in probe design and molecular barcoding enable efficient analysis of diverse and challenging sample types.

Recent filings

Filing Released Lang Actions
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Celemics' (주식회사 셀레믹스) covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial information, business overviews, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an individual (Bang Du Hee) regarding their holdings in Celemics. This type of filing, which details changes in share ownership by insiders or major shareholders, is classified as a Director's Dealing (DIRS) report in the provided schema.
2023-04-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required when an individual or entity crosses a specific ownership threshold in a company. In the context of the provided categories, this falls under 'Major Shareholding Notification' (MRQ), as it details the change in share ownership by a major shareholder (Bang Du-hee) and their special relations in the company Celemics.
2023-04-07 Korean
최대주주변경
Major Shareholding Notification Classification · 1% confidence The document is a formal regulatory filing from a Korean company (Celemix) announcing a change in its largest shareholder. It details the specific share counts and percentages before and after the change, the reason for the change (partial sale of shares by the previous largest shareholder), and provides background information on the new largest shareholder. This type of disclosure is a standard regulatory requirement for public companies to report changes in control or major shareholding structures, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Major Shareholding Notification' (which usually refers to external investors) or 'Director's Dealing' (which refers to individual trades).
2023-04-07 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director appointments, and remuneration limits. This aligns perfectly with the definition of a Declaration of Voting Results (DVA), which reports the official outcomes of shareholder votes at a general meeting.
2023-03-28 Korean
사업보고서 (2022.12)
Annual Report Classification · 1% confidence The document is a '사업보고서' (Business Report) for the 13th fiscal year (2022) of Celemics, Inc. It contains detailed company information, history, capital structure, and business descriptions. In the South Korean regulatory context, the '사업보고서' is the equivalent of the US 10-K annual report, providing comprehensive financial and operational disclosures for the full fiscal year. FY 2022
2023-03-21 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.